Our findings reveal that KF mitigates COPD progression by coordinately targeting the Nrf2/NCOA4/GPx4 axis to inhibit ferroptosis, providing a novel therapeutic strategy for oxidative stress‐driven pulmonary diseases. The gene discussed is NCOA4; the disease is chronic obstructive pulmonary disease.